Matrix

Matrix Partners is a venture capital firm established in 1977, with offices in San Francisco, Cambridge, Shanghai, Beijing, Mumbai, and Bangalore. The firm focuses on seed, early-stage, late-stage, and growth capital investments across various sectors, including software, communications, artificial intelligence, fintech, digital health, and clean technology. With a commitment to building long-term relationships with entrepreneurs, Matrix Partners aims to support visionary founders in developing significant, industry-leading companies. The firm has a strong track record, having participated in hundreds of investments, with many of its portfolio companies achieving successful IPOs or profitable mergers and acquisitions. The team at Matrix Partners combines local insights with global expertise, comprising both former entrepreneurs and seasoned investors.

Avnish Bajaj

Founder and Managing Director

Tim Barrows

Partner

Diana Kimball Berlin

Partner

Matthew Brown

Partner

Mollie Carter

Marketing Partner

Heng Deng

Associate

Phyllis Doherty

Administrative Partner

Jingze Feng

Senior Associate

Paul Ferri

Co-Founder

Josh Hannah

General Partner

Leona Hu

Senior Associate

Yuzhou Hu

Associate

Yunqiu Hu

Investment Manager

Jake Jolis

Partner

Zhuyan Li

Vice President

Cui Lin

VP

Zhuang Liu

Director

Patrick Malatack

Partner

Harry Man

Partner

Kojo Osei

Partner

Stan Reiss

Partner

Antonio Rodriguez

Partner

Yibo Shao

Founding Partner

Bo Shao

Founding Managing Partner

David Skok

Partner

Dana Stalder

Partner

Tuong Sing Su

Founding Managing Partner

Ilya Sukhar

Partner

Roger Sun

Director

Andrew Verhalen

Partner

Stella Wang

Director

Bingxing Wang

director

Min Xiao

Partner

Kevin Xiong

Partner

Zhiyun Yu

MD

Ying Zhang

Founding Managing Partner

David Zhang

Founding Managing Partner

Wei Zhou

VP

Joy Zhou

Director

Lingye Zuo

Partner

Past deals in 3D Technology

Luma AI

Series A in 2023
Luma AI is a company focused on enabling users to capture and experience the world in three dimensions. Its platform employs a neural capture and rendering system to transform casual smartphone photos into photorealistic 3D representations. This technology serves various industries, including e-commerce, real estate, and 3D gaming, allowing users to engage with multimedia content in a mixed-reality environment. By leveraging multimodal artificial intelligence, Luma AI aims to expand human imagination and capabilities, facilitating a more immersive experience in visual storytelling.

SpeedBot

Series B in 2022
SpeedBot is positioned as: the most powerful visual brain for 3D visual perception and robot flexible control in complex scenes for logistics, intelligent manufacturing, new retail, big health, etc.; providing low cost and high efficiency for robot complex interactive scenes 3D visual algorithm, end-of-line software and hardware integration, general vision computing platform services.

SpeedBot

Venture Round in 2022
SpeedBot is positioned as: the most powerful visual brain for 3D visual perception and robot flexible control in complex scenes for logistics, intelligent manufacturing, new retail, big health, etc.; providing low cost and high efficiency for robot complex interactive scenes 3D visual algorithm, end-of-line software and hardware integration, general vision computing platform services.

Deep View Technology

Series B in 2022
Beijing Deep View Technology Co., Ltd. engaged in research on 3D computer vision algorithm. The company is based in Beijing, China.

Triastek

Series B in 2021
Triastek Co. Ltd. manufactures 3D printed pharmaceuticals and related medical equipment. It offers blockbuster drugs, orphan drugs, and complex drug delivery technologies. It also offers drug 3D printing, such as three-dimensional drug structure formulation design, 3D printing pharmaceutical equipment, and drug product development methods for patent families in China, US, Europe, and Japan. The company also owns Melt Extrusion Deposition (MED), a 3D printing technology universally applicable to solid formulations. The company was founded in 2015 and is based in Nanjing, China.

Lightforce Orthodontics

Series C in 2021
LightForce Orthodontics addresses this problem by applying patented, next-generation manufacturing technology adapted for use in orthodontic treatment by the industry's leading experts. It enables orthodontists to utilize its 3D-printing technology to create custom braces for each individual patient, significantly reducing the number of adjustment visits needed.

Luma AI

Seed Round in 2021
Luma AI is a company focused on enabling users to capture and experience the world in three dimensions. Its platform employs a neural capture and rendering system to transform casual smartphone photos into photorealistic 3D representations. This technology serves various industries, including e-commerce, real estate, and 3D gaming, allowing users to engage with multimedia content in a mixed-reality environment. By leveraging multimodal artificial intelligence, Luma AI aims to expand human imagination and capabilities, facilitating a more immersive experience in visual storytelling.

Geopipe

Seed Round in 2021
Geopipe specializes in creating immersive digital twins of the real world through advanced machine learning and algorithmic tools. The company processes vast amounts of geographic and numeric data, including satellite images, maps, and laser scans, utilizing cloud-based distributed systems to reconstruct entire cities rapidly. This innovative approach allows for efficient simulations in various fields such as gaming, architecture, and urban planning. By providing real estate developers with authoritative digital representations, Geopipe helps streamline project timelines, ultimately saving time and costs in the development process.

Triastek

Series B in 2021
Triastek Co. Ltd. manufactures 3D printed pharmaceuticals and related medical equipment. It offers blockbuster drugs, orphan drugs, and complex drug delivery technologies. It also offers drug 3D printing, such as three-dimensional drug structure formulation design, 3D printing pharmaceutical equipment, and drug product development methods for patent families in China, US, Europe, and Japan. The company also owns Melt Extrusion Deposition (MED), a 3D printing technology universally applicable to solid formulations. The company was founded in 2015 and is based in Nanjing, China.

Lightforce Orthodontics

Series B in 2020
LightForce Orthodontics addresses this problem by applying patented, next-generation manufacturing technology adapted for use in orthodontic treatment by the industry's leading experts. It enables orthodontists to utilize its 3D-printing technology to create custom braces for each individual patient, significantly reducing the number of adjustment visits needed.

Lightforce Orthodontics

Venture Round in 2018
LightForce Orthodontics addresses this problem by applying patented, next-generation manufacturing technology adapted for use in orthodontic treatment by the industry's leading experts. It enables orthodontists to utilize its 3D-printing technology to create custom braces for each individual patient, significantly reducing the number of adjustment visits needed.